Hepatitis Monthly

Published by: Kowsar

The Prevalence of Hepatitis C Virus in Mashhad, Iran: A Population-Based Study

Mohammad Taghi Shakeri 1 , Hosein Nomani 2 , Majid Ghayour Mobarhan 3 , Hamid Reza Sima 4 , Sina Gerayli 5 , Shirin Shahbazi 2 , Sina Rostami 5 and Zahra Meshkat 6 , *
Authors Information
1 Department of Biostatistics, Public Health School, Mashhad University of Medical Sciences, Mashhad, IR Iran
2 Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, IR Iran
3 Biochemistry of Nutritional Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
4 Department of Internal Medicine, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, IR Iran
5 Department of Biology, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad, IR Iran
6 Women’s Health Research Center, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • Hepatitis Monthly: March 01, 2013, 13 (3); e7723
  • Published Online: March 12, 2013
  • Article Type: Research Article
  • Received: August 13, 2012
  • Revised: November 10, 2012
  • Accepted: December 9, 2012
  • DOI: 10.5812/hepatmon.7723

To Cite: Shakeri M T, Nomani H, Ghayour Mobarhan M, Sima H R, Gerayli S, et al. The Prevalence of Hepatitis C Virus in Mashhad, Iran: A Population-Based Study, Hepat Mon. 2013 ; 13(3):e7723. doi: 10.5812/hepatmon.7723.

Abstract
Copyright © 2013, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Alavian SM. Triangular clinics: The way of the future. Hepat Mon. 2005; 5(3): 51-2
  • 2. Somi MH, Keivani H, Ardalan MR, Farhang S, Pouri AA. Hepatitis C virus genotypes in patients with end-stage renal disease in East Azerbaijan, Iran. Saudi J Kidney Dis Transpl. 2008; 19(3): 461-5[PubMed]
  • 3. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. J Gastroenterol Hepatol. 2002; 17(10): 1092-7[PubMed]
  • 4. Tamaddoni A, Mohammadzadeh I, Ziaei O. Seroprevalence of HCV antibody among patients with beta-thalassemia major in Amirkola Thalassemia Center, Iran. Iran J Allergy Asthma Immunol. 2007; 6(1): 41[PubMed]
  • 5. Khattak MF, Salamat N, Bhatti FA, Qureshi TZ. Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc. 2002; 52(9): 398-402[PubMed]
  • 6. Arthur RR, Hassan NF, Abdallah MY, El-Sharkawy MS, Saad MD, Hackbart BG, et al. Hepatitis C antibody prevalence in blood donors in different governorates in Egypt. T Roy Soc Trop Med H. 1997; 91(3): 271-4
  • 7. Iwasa Y, Otsubo S, Sugi O, Sato K, Asamiya Y, Eguchi A, et al. Patterns in the prevalence of hepatitis C virus infection at the start of hemodialysis in Japan. Clin Exp Nephrol. 2008; 12(1): 53-7[DOI][PubMed]
  • 8. Selm SB. Prevalence of hepatitis C virus infection among hemodialysis patients in a single center in Yemen. Saudi J Kidney Dis Transpl. 2010; 21(6): 1165-8[PubMed]
  • 9. Alavian SM. Control of hepatitis C in Iran: vision and missions. Hepat Mon. 2007; 7(2): 57-8
  • 10. Al-Sweedan SA, Jaradat S, Amer K, Hayajneh W, Haddad H. Seroprevalence and genotyping of hepatitis C virus in multiple transfused Jordanian patients with β-thalassemia major. Turk J Hematol. 2011; 28: 47-51
  • 11. Alavian S, Hajarizadeh B. Prevalence of HCV, HBV and HIV infection among hemophiliacs patients. Hakim Res J. 2003; 6(45-51)
  • 12. Kabir A, Alavian SM, Keyvani H. Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study. Comp Hepatol. 2006; 5(4): 17014721
  • 13. Keyvani H, Alizadeh AH, Alavian SM, Ranjbar M, Hatami S. Distribution frequency of hepatitis C virus genotypes in 2231 patients in Iran. Hepatol Res. 2007; 37(2): 101-3[DOI][PubMed]
  • 14. Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy. 2007; 18(5): 352-8[DOI][PubMed]
  • 15. Azizi A, Amirian F. Prevalence and Associated Factors of Hepatitis C in Self-introduced Substance Abusers. HAYAT. 2011; 17(1)
  • 16. Haidar NA. Prevalence of hepatitis B and hepatitis C in blood donors and high risk groups in Hajjah, Yemen Republic. Saudi Med J. 2002; 23(9): 1090-4[PubMed]
  • 17. al-Faleh FZ, Ayoola EA, al-Jeffry M, al-Rashed R, al-Mofarreh M, Arif M, et al. Prevalence of antibody to hepatitis C virus among Saudi Arabian children: a community-based study. Hepatology. 1991; 14(2): 215-8[PubMed]
  • 18. Hosseini-Moghaddam SM, Keyvani H, Kasiri H, Kazemeyni SM, Basiri A, Aghel N, et al. Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran--a multicenter study. J Med Virol. 2006; 78(5): 569-73[DOI][PubMed]
  • 19. Taziki O, Espahbodi F. Prevalence of hepatitis C virus infection in hemodialysis patients. Saudi J Kidney Dis Transpl. 2008; 19(3): 475-8[PubMed]
  • 20. Samimi-Rad K, Hosseini M. Hepatitis C virus infection and hcv genotypes of hemodialysis patients. Iranian J Pub Health. 2008; 37(3)
  • 21. Espinosa M, Martn-Malo A, Ojeda R, Santamara R, Soriano S, Aguera M, et al. Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients: causes and consequences. Am J Kidney Dis. 2004; 43(4): 685-9[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments